PubMed

Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate.

Deveras RA, Kessler CM.

Ann Intern Med. 2002 Dec 3;137(11):884-8.PMID: 12458988 [PubMed - indexed for MEDLINE]Related articlesFree article

Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.

Dager WE, King JH, Regalia RC, Williamson D, Gosselin RC, White RH, Tharratt RS, Albertson TE.

Pharmacotherapy. 2006 Aug;26(8):1091-8.PMID: 16863486 [PubMed - indexed for MEDLINE]Related articles

Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects.

Sørensen B, Johansen P, Nielsen GL, Sørensen JC, Ingerslev J.

Blood Coagul Fibrinolysis. 2003 Jul;14(5):469-77.PMID: 12851533 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. A new way to reverse excessive blood thinning from warfarin.

[No authors listed]

Ann Intern Med. 2002 Dec 3;137(11):I41. No abstract available. PMID: 12459002 [PubMed - indexed for MEDLINE]Related articlesFree article

Recombinant factor VIIa for warfarin-associated intracranial bleeding.

Ilyas C, Beyer GM, Dutton RP, Scalea TM, Hess JR.

J Clin Anesth. 2008 Jun;20(4):276-9.PMID: 18617125 [PubMed - indexed for MEDLINE]Related articles

Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage.

Freeman WD, Brott TG, Barrett KM, Castillo PR, Deen HG Jr, Czervionke LF, Meschia JF.

Mayo Clin Proc. 2004 Dec;79(12):1495-500.PMID: 15595332 [PubMed - indexed for MEDLINE]Related articlesFree article

Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.

Yasaka M, Sakata T, Naritomi H, Minematsu K.

Thromb Res. 2005;115(6):455-9.PMID: 15792675 [PubMed - indexed for MEDLINE]Related articles

The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings.

Lin J, Hanigan WC, Tarantino M, Wang J.

J Neurosurg. 2003 Apr;98(4):737-40.PMID: 12691397 [PubMed - indexed for MEDLINE]Related articles

Use of recombinant factor VIIa for emergency reversal of anticoagulation.

Ingerslev J, Vanek T, Culic S.

J Postgrad Med. 2007 Jan-Mar;53(1):17-22.PMID: 17244965 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage.

Brody DL, Aiyagari V, Shackleford AM, Diringer MN.

Neurocrit Care. 2005;2(3):263-7.PMID: 16159073 [PubMed - indexed for MEDLINE]Related articlesFree article

Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.

Denas G, Marzot F, Offelli P, Stendardo A, Cucchini U, Russo R, Nante G, Iliceto S, Pengo V.

J Thromb Thrombolysis. 2009 Apr;27(3):340-7. Epub 2008 Mar 13.PMID: 18338109 [PubMed - indexed for MEDLINE]Related articles

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE.

Arch Intern Med. 2000 Jun 12;160(11):1612-7.PMID: 10847254 [PubMed - indexed for MEDLINE]Related articlesFree article

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.

Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group.

J Thromb Haemost. 2008 Apr;6(4):622-31. Epub 2008 Jan 15.PMID: 18208533 [PubMed - indexed for MEDLINE]Related articles

Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.

Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin H, Ezra D.

Arch Intern Med. 2003 Nov 10;163(20):2469-73.PMID: 14609783 [PubMed - indexed for MEDLINE]Related articlesFree article

Recombinant FVIIa in the treatment of warfarin bleeding.

Berntorp E.

Semin Thromb Hemost. 2000;26(4):433-5. Review.PMID: 11092220 [PubMed - indexed for MEDLINE]Related articles

Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation.

Tanaka KA, Szlam F, Dickneite G, Levy JH.

Thromb Res. 2008;122(1):117-23. Epub 2007 Oct 31.PMID: 17977586 [PubMed - indexed for MEDLINE]Related articles

Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.

Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ.

Ann Intern Med. 2001 Sep 18;135(6):393-400.PMID: 11560452 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.

Patel RJ, Witt DM, Saseen JJ, Tillman DJ, Wilkinson DS.

Pharmacotherapy. 2000 Oct;20(10):1159-66.PMID: 11034038 [PubMed - indexed for MEDLINE]Related articles

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.

Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE.

Ann Intern Med. 2004 Nov 16;141(10):745-52.PMID: 15545674 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis.

Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C.

Pharmacotherapy. 2007 Sep;27(9):1237-47.PMID: 17723077 [PubMed - indexed for MEDLINE]Related articles